Results 101 to 110 of about 261 (136)

Large language model produces high accurate diagnosis of cancer from end-motif profiles of cell-free DNA. [PDF]

Brief Bioinform
Liu J, Shen H, Chen K, Li X.
europepmc   +1 more source

Novel Biomarkers in Hepatocellular Carcinoma from Embryogenic Antigens to cfDNA. [PDF]

Biomedicines
Ghantus R, Ciocan RA, Schlanger D, Popa C, Gherman CD, Vaida C, Gherman B, Pîslă D, Al Hajjar N, Ciocan A.   +9 more
europepmc   +1 more source

Development of a deep learning model for cancer diagnosis by inspecting cell-free DNA end-motifs. [PDF]

NPJ Precis Oncol
Shen H, Yang M, Liu J, Chen K, Li X.
europepmc   +1 more source

Capturing the 3′ fragmentome: Transcriptome-wide identification of endogenous NMD targets and analysis of their endonucleolytic decay

, 2017
Ottens, Franziska
core  

Cell-free DNA methylome and fragmentome analysis for disease relapse monitoring in patients with Ewing Sarcoma

Richardson SA, Gulati G, Harker PJ, Redfern A, Pearce SP, Karimpour M, Hill SM, Makeev VJ, Brennan B, Lee AT, Clipson A, Dive C, Rothwell DG, McCabe MG, Mouliere F.   +14 more
europepmc   +1 more source

Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer. [PDF]

Sci Adv
Hruban C, Bruhm DC, Chen IM, Koul S, Annapragada AV, Vulpescu NA, Short S, Theile S, Boyapati K, Alipanahi B, Skidmore ZL, Leal A, Cristiano S, Adleff V, Johannsen JS, Scharpf RB, Foda ZH, Phallen J, Velculescu VE.   +18 more
europepmc   +1 more source

Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors. [PDF]

Cancer Discov
Stutheit-Zhao EY, Sanz-Garcia E, Liu ZA, Wong D, Marsh K, Abdul Razak AR, Spreafico A, Bedard PL, Hansen AR, Lheureux S, Torti D, Lam B, Yang SYC, Burgener J, Luo P, Zeng Y, Cheng N, Awadalla P, Bratman SV, Ohashi PS, Pugh TJ, Siu LL.   +21 more
europepmc   +1 more source

A Review of Circulating Tumor DNA (ctDNA) and the Liquid Biopsy in Cancer Diagnosis, Screening, and Monitoring Treatment Response. [PDF]

Med Sci Monit
Parums DV.
europepmc   +1 more source

Advances in translational lung cancer research in 2025: a narrative review. [PDF]

Transl Lung Cancer Res
Xu Y, Kuang Y, Guo Y, Lou Y.
europepmc   +1 more source

Beyond mutations: epigenetic and fragmentomic landscapes of cfDNA in lung cancer

Expert Review of Molecular Diagnostics
Jing Liu, Laura S.E. Schulz, Qing Zhou
openaire   +1 more source